GnRH antagonist administration for patients at high risk of severe ovarian hyperstimulation syndrome (OHSS) down regulated GnRH agonist
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2009
At a glance
- Drugs Ganirelix (Primary) ; Gonadotropin releasing hormone stimulants; Menotropin
- Indications Infertility; Ovarian hyperstimulation syndrome
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2006 New trial record.